免疫调节心肌纤维化
Maurits A Sikking1, Sophie L V M Stroeks1, Federica Marelli-Berg2
1Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC), Maastricht, the Netherlands.
JACC. Basic to translational science
|December 14, 2023
概括
免疫疗法通过调节免疫细胞和心脏纤维细胞来治疗心肌纤维化是一种有希望的方法. 针对这些途径可能会导致心力衰竭的创新治疗方法.
科学领域:
- 心血管免疫学心血管免疫学
- 纤维化研究纤维化.
- 免疫调节疗法是一种免疫调节疗法.
背景情况:
- 心肌纤维化是心力衰竭发展的一个重要因素.
- 由天生的和适应性免疫驱动的炎症过程会加剧纤维化.
- 心脏纤维细胞在心力衰竭期间的心脏重塑中发挥着至关重要的作用.
研究的目的:
- 审查治疗心肌纤维化的新型免疫调节策略.
- 探索针对心脏纤维细胞激活和分化的治疗方法.
- 讨论操纵纤维化免疫反应的临床潜力.
主要方法:
- 关于免疫疗法和心肌纤维化目前文献的综述.
- 针对纤维细胞的免疫调节策略的分析.
- 关于天生的和适应性免疫系统操纵的讨论.
主要成果:
- 免疫疗法是心肌纤维化治疗的潜在基石.
- 策略包括向纤维细胞与仿真抗原受体T细胞,介质蛋白-11,和不变的自然杀手T细胞.
- 对先天性和适应性免疫的操纵对于临床转化至关重要.
结论:
- 需要创新的免疫调节方法来对抗心肌纤维化.
- 准心脏纤维细胞和免疫细胞有望降低心力衰竭风险.
- 进一步的研究对于这些治疗策略的临床验证至关重要.
更多相关视频
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
7.3K
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
4.6K
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594
